Rexahn Pharmaceuticals CEO Mina Sooch's 2021 pay jumps 66% to $801K
Rexahn Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Rexahn Pharmaceuticals reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, three executives at Rexahn Pharmaceuticals received on average a compensation package of $486K, a 20% decrease compared to previous year.
Average pay of disclosed executives at Rexahn Pharmaceuticals
Mina Sooch, Chief Executive Officer, received $801K in total, which increased by 66% compared to 2020. 66% of Sooch's compensation, or $525K, was in salary. Sooch also received $247K in non-equity incentive plan and $29K in other compensation.
Amy Rabourn, Vice President of Finance, received a compensation package of $332K, which increased by 25% compared to previous year. 72% of the compensation package, or $240K, was in salary.
Bernhard Hoffmann, Vice President of Corporate Development and Operations, earned $325K in 2021, a 219% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2022.